Serum concentrations of steroids, parathyroid hormone, and calcitonin in postmenopausal women during the year following hip fracture: Effect of location of fracture and age

被引:13
作者
Dubin, NH
Monahan, LK
Yu-Yahiro, JA
Michael, RH
Zimmerman, SI
Hawkes, W
Hebel, JR
Fox, KM
Magaziner, J
机构
[1] Union Mem Hosp, Dept Obstet & Gynecol, Baltimore, MD 21218 USA
[2] Union Mem Hosp, Dept Orthoped, Baltimore, MD 21218 USA
[3] Univ Maryland, Dept Epidemiol, Baltimore, MD 21201 USA
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 1999年 / 54卷 / 09期
关键词
D O I
10.1093/gerona/54.9.M467
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. Hip fracture in the aged is a major health problem, especially considering the increasing proportion of the elderly in the population. This study examines changes in circulating levels of hormones, which are purported to affect bone metabolism, in response to hip fracture in postmenopausal women. Methods. Patients consisted of women ages 65 and older who had surgery within 2 days of fracture. Serum samples were obtained at 3, 10, 60, 180, and 360 days postfracture. Healthy women without hip fractures from the same age range served as a control group (n = 17). Hormones were determined by radioimmunoassay. Subjects with fractures in the neck region of the femur (n = 78) were compared to subjects with fractures in the trochanteric region (n = 88). Results. Estrone concentration (47.6 +/- 5.7 pg/mL; mean +/- SEM) at 3 days postfracture was elevated (p < .001) compared to control levels of 20.7 +/- 3.6 pg/mL. By 2 months, levels had declined to control levels. Androstenedione and the adrenal hormones, DHEAS and cortisol, displayed similar responses. Parathyroid hormone (PTH) levels were not significantly different from the control concentration at 3 days following fracture, but increased (p < .001) during the year following fracture. Calcitonin concentrations were much higher (p < .001) 3 days postfracture (42.1 +/- 3.7 pg/mL) compared to controls without fracture (9.8 +/- 3 pg/mL). Except for testosterone, no differences could be attributed to fracture location. Only PTH, with concentrations higher in the older age groups (p < .001), showed an age-related response. Conclusions, Following hip fracture, there are some dramatic responses in hormones that purportedly are mechanistically important in bone metabolism. These changes include transient increases in steroid hormones, chronic elevations in calcitonin, and rising levels of MN during the year after fracture.
引用
收藏
页码:M467 / M473
页数:7
相关论文
共 46 条
[11]   INFLUENCE OF AGE AND SEX ON PLASMA CALCITONIN IN HUMAN-BEINGS [J].
DEFTOS, LJ ;
WEISMAN, MH ;
WILLIAMS, GW ;
KARPF, DB ;
FRUMAR, AM ;
DAVIDSON, BJ ;
PARTHEMORE, JG ;
JUDD, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (24) :1351-1353
[12]   LONG-TERM ESTROGEN REPLACEMENT THERAPY PREVENTS BONE LOSS AND FRACTURES [J].
ETTINGER, B ;
GENANT, HK ;
CANN, CE .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :319-324
[13]   OSTEOPOROSIS IN MEN WITH IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM [J].
FINKELSTEIN, JS ;
KLIBANSKI, A ;
NEER, RM ;
GREENSPAN, SL ;
ROSENTHAL, DI ;
CROWLEY, WF .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (03) :354-361
[14]   THE EFFECT OF AGING ON INTACT PTH AND BONE-DENSITY IN WOMEN [J].
FLICKER, L ;
LICHTENSTEIN, M ;
COLMAN, P ;
BUIRSKI, G ;
KAYMAKCI, B ;
HOPPER, JL ;
WARK, JD .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1992, 40 (11) :1135-1138
[15]   ENDOCRINE CAUSES OF BONE-DISEASE [J].
GUPTA, KL ;
ROLLA, AR .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1995, 24 (02) :373-393
[16]  
HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649
[17]   Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta [J].
Hughes, DE ;
Dai, AH ;
Tiffee, JC ;
Li, HH ;
Mundy, GR ;
Boyce, BF .
NATURE MEDICINE, 1996, 2 (10) :1132-1136
[18]   Reliability of parathyroid hormone measurements in the period immediately following hip fracture [J].
Johansen, A ;
Stone, MD ;
OMahony, MS ;
Westlake, H ;
Woodhead, JS ;
Woodhouse, KW .
AGE AND AGEING, 1997, 26 (03) :175-178
[19]   TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - IS THE ANABOLIC-STEROID NANDROLONE DECANOATE A CANDIDATE [J].
JOHANSEN, JS ;
HASSAGER, C ;
PODENPHANT, J ;
RIIS, BJ ;
HARTWELL, D ;
THOMSEN, K ;
CHRISTIANSEN, C .
BONE AND MINERAL, 1989, 6 (01) :77-86
[20]   Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway [J].
Kaji, H ;
Sugimoto, T ;
Kanatani, M ;
Nasu, M ;
Chihara, K .
ENDOCRINOLOGY, 1996, 137 (06) :2217-2224